Streetbeat News

Earnings

GIFI

Gulf Island Fabrication's stock price increased following the announcement of their Q4 earnings.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:05 pm

REGN

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that The Lancet published results from the PULSAR and PHOTON trials for EYLEA HD (aflibercept) Injection 8 mg, showing it was non-inferior to EYLEA 2 mg in treating wet age-related macular degeneration (wAMD) and diabetic macular edema (DME).

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:05 pm

OWLT

Owlet shares are trading lower following the announcement of worse-than-expected Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:05 pm

PRCH

Porch Group's shares surged following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided optimistic guidance for FY24, further boosting investor confidence.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:04 pm

MGNX

MacroGenics, Inc. (MGNX) shares are trading lower following the announcement of their Q4 results.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:04 pm

SWBI

Smith & Wesson Brands' shares surged following the announcement of their Q3 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:03 pm

DOMO

Domo shares are trading lower following the company's announcement of weaker than expected guidance for Q1 and the full fiscal year 2025.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:01 pm

ATHA

Athira Pharma, Inc. (NASDAQ:ATHA) presented new clinical and preclinical data at the AD/PD 2024 International Conference, supporting the therapeutic potential of fosgonimeton in treating Alzheimer's and Parkinson's diseases. The conference took place in Lisbon, Portugal from March 5 to 9, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:01 pm

FNKO

Funko's stock price increased following the announcement of their Q4 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:01 pm

DECK

Deckers Outdoor Corp (NYSE:DECK) has been analyzed by 17 analysts, showing a shift towards a more bullish sentiment over the last three months. The average 12-month price target for DECK has increased to $873.94, up 15.95% from the previous target. Analysts have adjusted their ratings and price targets, reflecting optimism about the company's performance and market position. Deckers Outdoor, known for brands like UGG and Teva, has shown strong financial performance with significant revenue growth, high net margin, and impressive ROE and ROA, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 12:00 pm